Other Ingredients: Cellulose, Stearic Acid (vegetable source), Magnesium Stearate (vegetable source), Silica and Vegetarian Coating

patients with symptomatic decline (poor sleep, body composition changes, reduced energy) may be candidates Patients with body composition goals where GH optimization is clinically relevant: body fat accumulation alongside lean mass reduction that has not responded adequately to lifestyle intervention Individuals seeking sleep quality improvement where GH-axis optimization is part of the clinical picture Athletes or active individuals with recovery requirements where GH-mediated protein synthesis is a clinical priority Patients already in a comprehensive longevity program where GH-axis assessment and optimization is part of the protocol The decision to prescribe Ipamorelin or any GH secretagogue begins with a clinical assessment that includes baseline IGF-1 measurement (the primary marker of GH axis activity), review of the patient's symptom profile, and evaluation of contraindications
Where can I view the third-party testing results for this batch
Technical Information Molecular Formula: C14H24CuN6O4 Molecular Weight: ~403.92 g/mol Synonyms: GHK-Cu, Cu-GHK, Copper Tripeptide-1, Glycyl-L-histidyl-L-lysine copper complex This product is intended strictly for laboratory and scientific research only
Each of these pharmaceutical classes can enhance glycemic control and carry ancillary benefits, including weight reduction and decreased cardiovascular risk